Crucell
AcquiredNetherlands · $97.0M raised
- Total Funding
- $97.0M
- Last Round
- $97.0M Venture RoundJan 2001
- Rounds
- 1
About
Novel vaccine platform
Summary
Crucell is a biotechnology company based in Netherlands. It has raised $97.0M in total across 1 round, most recently a $97.0M Venture Round round in Jan 2001. Investors include Johnson & Johnson, Alta Partners and Atlas Venture.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Apr 2011
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Clinical-stage biotech developing innovative sustained-release therapeutics for serious retinal d...
Biotechnology company focused on developing and commercializing innovative, empowered monoclonal ...
BridgeBio makes targeted treatments for genetic diseases.
Novel bicyclic peptides and drug conjugates for cancer
Biotechnology company focused on the development of antibody-drug conjugates for the treatment of...
R&D company with 6 SBIR/STTR awards from Department of Health and Human Services.